Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Fortral
2. Hydrochloride, Pentazocine
3. Lactate, Pentazocine
4. Lexir
5. Pentazocine
6. Pentazocine Hydrochloride
7. Talwin
1. 17146-95-1
2. Pentazocine Lactate [usan]
3. 1p2xib510o
4. (1r,9r,13r)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;2-hydroxypropanoic Acid
5. (2r*,6r*,11r*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol Lactate (salt)
6. Talwin (lactate)
7. Pentalgine
8. Talwin (as Lactate)
9. Unii-1p2xib510o
10. Talwin Injection
11. Einecs 241-209-9
12. Einecs 304-943-1
13. Talwin (tn)
14. Pentazocine Lactate (usp)
15. Schembl42094
16. (all-r)-pentazocine Dl-lactate
17. Chembl1200327
18. Pentazocine Lactate [mi]
19. Dtxsid101027503
20. Pentazocine Lactate [vandf]
21. Pentazocine Lactate [mart.]
22. Pentazocine Lactate [who-dd]
23. Pentazocine Lactate [green Book]
24. Pentazocine Lactate [orange Book]
25. 2-hydroxypropanoic Acid Compd. With (2alpha,6alpha,11r*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methanol-3-benzocin-8-ol (1:1)
26. Lactic Acid, Compd. With 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol (1:1)
27. Lactic Acid, Compound With (2alpha,6alpha,11r*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzocin-8-ol (1:1)
28. Pentazocine Lactate [ep Monograph]
29. D02111
30. Q27252701
31. 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2.alpha.,6.alpha.,11r*)-, Compd. With 2-hydroxypropanoic Acid (1:1)
32. 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11r*)-, Compd. With 2-hydroxypropanoic Acid (1:1)
33. Propanoic Acid, 2-hydroxy-, Compd. With (2alpha,6alpha,11r*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methanol-3-benzocin-8-ol (1:1)
| Molecular Weight | 375.5 g/mol |
|---|---|
| Molecular Formula | C22H33NO4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 375.24095853 g/mol |
| Monoisotopic Mass | 375.24095853 g/mol |
| Topological Polar Surface Area | 81 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 473 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

About the Company : Farbe Firma was incorporated in the year 2012. It was started as a Dyes’ and Pharmaceutical intermediates trading company. We have now ventured to diversify into Injectable Pharm...

About the Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and importing pharmaceutica...

About the Company : Valence has worked diligently to position itself as a top global manufacturer of high-quality APIs, driven by an unwavering commitment to product excellence. As we advance on this ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Pentazocine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hot Flashes.
Lead Product(s): Pentazocine,Naloxone Hydrochloride
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | National Center for Advancing Translational Sciences
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 25, 2014

Lead Product(s) : Pentazocine,Naloxone Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | National Center for Advancing Translational Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Kappa Agonist on Hot Flashes in Menopausal Women
Details : Pentazocine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hot Flashes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2014

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
13
PharmaCompass offers a list of Pentazocine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pentazocine manufacturer or Pentazocine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pentazocine manufacturer or Pentazocine supplier.
PharmaCompass also assists you with knowing the Pentazocine API Price utilized in the formulation of products. Pentazocine API Price is not always fixed or binding as the Pentazocine Price is obtained through a variety of data sources. The Pentazocine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Talwin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Talwin, including repackagers and relabelers. The FDA regulates Talwin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Talwin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Talwin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Talwin supplier is an individual or a company that provides Talwin active pharmaceutical ingredient (API) or Talwin finished formulations upon request. The Talwin suppliers may include Talwin API manufacturers, exporters, distributors and traders.
click here to find a list of Talwin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Talwin DMF (Drug Master File) is a document detailing the whole manufacturing process of Talwin active pharmaceutical ingredient (API) in detail. Different forms of Talwin DMFs exist exist since differing nations have different regulations, such as Talwin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Talwin DMF submitted to regulatory agencies in the US is known as a USDMF. Talwin USDMF includes data on Talwin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Talwin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Talwin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Talwin Drug Master File in Japan (Talwin JDMF) empowers Talwin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Talwin JDMF during the approval evaluation for pharmaceutical products. At the time of Talwin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Talwin suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Talwin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Talwin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Talwin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Talwin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Talwin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Talwin suppliers with NDC on PharmaCompass.
Talwin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Talwin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Talwin GMP manufacturer or Talwin GMP API supplier for your needs.
A Talwin CoA (Certificate of Analysis) is a formal document that attests to Talwin's compliance with Talwin specifications and serves as a tool for batch-level quality control.
Talwin CoA mostly includes findings from lab analyses of a specific batch. For each Talwin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Talwin may be tested according to a variety of international standards, such as European Pharmacopoeia (Talwin EP), Talwin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Talwin USP).